Searched over 200M research papers
10 papers analyzed
These studies suggest abnormal development or growth of cells is known as neoplasia or cancer.
20 papers analyzed
Neoplasia is a condition characterized by abnormal cell differentiation and growth. This pathological process involves the transformation of normal cells into neoplastic cells, which exhibit abnormal characteristics and behaviors. Neoplasms, commonly referred to as tumors, can be classified as benign or malignant based on their growth patterns and potential to spread. The classification of neoplasms often focuses on the abnormal characteristics of the cells rather than the underlying mechanisms causing the transformation.
A neoplasm is an abnormal mass of tissue resulting from excessive and uncoordinated cell proliferation. This growth persists even after the removal of the initial stimuli that triggered the change. The persistence of tumors is due to inheritable genetic alterations that allow for unregulated and autonomous cell proliferation. Tumors are clonal, meaning they originate from a single cell that has undergone genetic changes. Histologically, abnormal cell growth can be observed in various tissues, including epithelial and stromal cells, leading to different types of cancers such as carcinoma, sarcoma, and lymphoma.
Cancer is a term used to describe a group of more than 100 distinct diseases characterized by abnormal cell growth and the potential to metastasize, or spread, to other parts of the body. Cancer can affect any tissue and manifest in various forms, including leukemia, lymphoma, breast cancer, brain cancer, and many others. The uncontrolled proliferation of cancer cells is often due to genetic mutations that disrupt normal cell signaling and growth regulation.
The development of abnormal cell growth, particularly malignant growth, involves several key conditions. These include the presence of a cell group in an indifferent stage of growth, dissociation from surrounding tissues, transition to a proliferative stage, inflammation of neighboring connective tissue, and altered cellular metabolism. Experimental models have demonstrated that these conditions can lead to the formation of abnormal growths, such as cysts and tumors, in various tissues.
Tumors, or neoplasms, are pathological disturbances of cell growth characterized by excessive and abnormal cell proliferation. Benign tumors are confined to their site of origin and exhibit normal cellular characteristics, whereas malignant tumors, or cancers, consist of abnormal cells that grow uncontrollably and have the potential to invade other tissues. The distinction between benign and malignant tumors is crucial for determining the appropriate treatment and prognosis.
Aneuploidy, or abnormal chromosome content, is a common feature of human solid tumors. It is proposed that aneuploidy contributes to tumor development by generating genetic instability. The mitotic checkpoint, which ensures proper chromosome segregation during cell division, plays a critical role in preventing aneuploidy. Defects in this checkpoint can lead to aneuploidy and facilitate tumorigenesis, making it a potential target for cancer therapy.
Abnormal patterns of brain growth, including both overgrowth and undergrowth, are observed in individuals with autism spectrum disorder (ASD). Mutations in the PTEN gene, which regulates the PI3K-Akt-mTOR pathway, are associated with ASD and macrocephaly. Studies in mouse models have shown that PTEN haploinsufficiency leads to brain overgrowth driven by hyperplasia and an imbalance in neuronal and glial cell populations. This abnormal growth is regulated by the interplay between PTEN and β-catenin signaling pathways.
Abnormal development or growth of cells, known as neoplasia, encompasses a wide range of pathological conditions characterized by unregulated cell proliferation. This can lead to the formation of benign or malignant tumors, with the latter having the potential to invade other tissues and metastasize. Understanding the genetic and cellular mechanisms underlying abnormal cell growth is crucial for developing effective cancer therapies and improving patient outcomes.
Most relevant research papers on this topic
258 Citations